Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Irritable Bowel Syndrome, January 2025

Free Subscription


Abstracts

Retrieve all available abstracts of the following 69 articles:
HTML format


 

Single Articles

  1. MANIPIS K, Cronin P, Street D, Church J, et al
    Examination of Methods to Estimate Productivity Losses in an Economic Evaluation: Using Foodborne Illness as a Case Study.
    Pharmacoeconomics. 2025 Jan 4. doi: 10.1007/s40273-024-01458.
    PubMed    
    Abstract available

  2. FASSOV J, Hoyer KL, Lundby L, Laurberg S, et al
    Long-term efficacy and safety of sacral neuromodulation for diarrhoea-predominant and mixed irritable bowel syndrome.
    Tech Coloproctol. 2025;29:41.
    PubMed    
    Abstract available

  3. WANG Y, Zhao Z, Wang R, Hu X, et al
    Genetic Links Between Gastrointestinal Disorders and Kidney Stone Disease: Insights from Genome-Wide Cross-Trait Analysis.
    Kidney360. 2025 Jan 3. doi: 10.34067/KID.0000000689.
    PubMed    
    Abstract available

  4. WARNER MM, Soliman OM, Crichton M, Marshall S, et al
    Systematic Review: Integrated Models of Care for Managing Irritable Bowel Syndrome.
    Neurogastroenterol Motil. 2025 Jan 3:e14989. doi: 10.1111/nmo.14989.
    PubMed    
    Abstract available

  5. ZHANG Q, Xu Y, Guo D, He H, et al
    Classification of Irritable Bowel Syndrome Using Brain Functional Connectivity Strength and Machine Learning.
    Neurogastroenterol Motil. 2025 Jan 3:e14994. doi: 10.1111/nmo.14994.
    PubMed    
    Abstract available

  6. ZAJAC DJ, Xu J, Cheng F
    Basic Science and Pathogenesis.
    Alzheimers Dement. 2024;20 Suppl 1:e092389.
    PubMed    
    Abstract available

  7. WAN X, Wang L, Wang Z, Wan C, et al
    Toll-like receptor 4 plays a vital role in irritable bowel syndrome: a scoping review.
    Front Immunol. 2024;15:1490653.
    PubMed    
    Abstract available

  8. SARNOFF RP, Hreinsson JP, Kim J, Sperber AD, et al
    Sex Differences, Menses-Related Symptoms and Menopause in Disorders of Gut-Brain Interaction.
    Neurogastroenterol Motil. 2025 Jan 2:e14977. doi: 10.1111/nmo.14977.
    PubMed    
    Abstract available

  9. YANG J, Yue K, Sun J, Pan C, et al
    Altered functional network topology properties to detect anxiety and depression caused by Crohn's disease and disease severity.
    Brain Res Bull. 2024 Dec 31:111187. doi: 10.1016/j.brainresbull.2024.111187.
    PubMed    
    Abstract available

  10. GOZDZIEWSKA M, Lyszczarz A, Kaczoruk M, Kolarzyk E, et al
    Relationship between SIBO and other bowel diseases and a common eating pattern for them. Part III.
    Ann Agric Environ Med. 2024;31:322-328.
    PubMed    
    Abstract available

  11. CHANGELA S, Ashraf S, Lu JY, Duong KE, et al
    New-onset gastrointestinal disorders in COVID-19 patients 3.5 years post-infection in the inner-city population in the Bronx.
    Sci Rep. 2024;14:31850.
    PubMed    
    Abstract available

  12. SCHMIDT S, Loef M, Ostermann T, Walach H, et al
    Treatment Effects in Pharmacological Clinical Randomized Controlled Trials are Mainly Due to Placebo.
    J Clin Epidemiol. 2024 Dec 27:111658. doi: 10.1016/j.jclinepi.2024.111658.
    PubMed    
    Abstract available

  13. FAN Z, Shao C, Kou Z, Xie F, et al
    The Role of Sex Hormones and Sex Hormone-binding Globulin in Functional Gatrointestinal Disorders: A Bidirectional Two-sample Mendelian Randomization Study.
    J Gastrointestin Liver Dis. 2024;33:474-481.
    PubMed    
    Abstract available

  14. TEGEGNE HA, Savidge TC
    Leveraging human microbiomes for disease prediction and treatment.
    Trends Pharmacol Sci. 2024 Dec 27:S0165-6147(24)00248.
    PubMed    
    Abstract available

  15. GASIOROWSKA A, Romanowski M, Walecka-Kapica E, Kaczka A, et al
    Efficacy and Safety of a Mixture of Microencapsulated Sodium Butyrate, Probiotics, and Short Chain Fructooligosaccharides in Patients with Irritable Bowel Syndrome-A Randomized, Double-Blind, Placebo-Controlled Study.
    J Clin Med. 2024;14:6.
    PubMed    
    Abstract available

  16. GARCIA MANSILLA MJ, Rodriguez Sojo MJ, Lista AR, Ayala Mosqueda CV, et al
    Exploring Gut Microbiota Imbalance in Irritable Bowel Syndrome: Potential Therapeutic Effects of Probiotics and Their Metabolites.
    Nutrients. 2024;17:155.
    PubMed    
    Abstract available

  17. GIAMMONA A, Galuzzi BG, Imperia E, Gervasoni C, et al
    Chronic Gastrointestinal Disorders and miRNA-Associated Disease: An Up-to-Date.
    Int J Mol Sci. 2025;26:413.
    PubMed    
    Abstract available

  18. HOYER KL, Dahl Baunwall SM, Kornum DS, Klinge MW, et al
    Faecal microbiota transplantation for patients with diabetes type 1 and severe gastrointestinal neuropathy (FADIGAS): a randomised, double-blinded, placebo-controlled trial.
    EClinicalMedicine. 2024;79:103000.
    PubMed    
    Abstract available

  19. AYDEMIR C, Al Saidi R, Choi JS, Ahmed MH, et al
    Bariatric surgery and HIV: Joint venture between family, primary care, and HIV physicians.
    J Family Med Prim Care. 2024;13:5920-5923.
    PubMed    
    Abstract available

  20. SINGH S, Srivastava NK, Yadav R, Paul S, et al
    Acute gastrointestinal and post-acute COVID-19 gastrointestinal syndrome assessment on the Gastrointestinal Symptom Rating Scale scoring system: A questionnaire-based survey.
    J Family Med Prim Care. 2024;13:5787-5798.
    PubMed    
    Abstract available

  21. DELLSCHAFT N, Murray K, Ren Y, Marciani L, et al
    Assessing Water Content of the Human Colonic Chyme Using the MRI Parameter T1: A Key Biomarker of Colonic Function.
    Neurogastroenterol Motil. 2025 Jan 10:e14999. doi: 10.1111/nmo.14999.
    PubMed    
    Abstract available

  22. HAMID N, Kueh YC, Muhamad R, Zahari Z, et al
    Complex and Bidirectional Interplay Between Marital Quality, Catastrophizing, Psychological Dysfunction, and Quality of Life in Married Malay Women With Disorder of Gut-Brain Interactions.
    Neurogastroenterol Motil. 2025 Jan 9:e15000. doi: 10.1111/nmo.15000.
    PubMed    
    Abstract available

  23. HAEDRICH J, Huber R
    Crohn's disease, irritable bowel syndrome, and chronic fatigue: the importance of communication and symptom management-a case report.
    J Med Case Rep. 2025;19:9.
    PubMed    
    Abstract available

  24. KRYNICKA P, Kaczmarczyk M, Skonieczna-Zydecka K, Cembrowska-Lech D, et al
    The burden of irritable bowel syndrome and functional dyspepsia in Poland: a cross-sectional study from West Pomeranian Voivodship.
    BMC Gastroenterol. 2025;25:8.
    PubMed    
    Abstract available

  25. CHENG S, Xiao W, Shi F, Zhao Z, et al
    A Bifunctional "Two-in-One" Array for Simultaneous Diagnosis of Irritable Bowel Syndrome and Identification of Low-FODMAP Diets.
    J Agric Food Chem. 2025 Jan 9. doi: 10.1021/acs.jafc.4c08690.
    PubMed    
    Abstract available

  26. HOLM IM, Lorentzen SCS, Carlsen MH, Valeur J, et al
    Evaluation of dietary quality in patients with functional gastrointestinal symptoms: a Norwegian single centre study.
    Food Nutr Res. 2024;68.
    PubMed    
    Abstract available

  27. IQBAL M, Hira S, Saeed H, Shahid S, et al
    Efficacy of Amitriptyline in Irritable Bowel Syndrome: A Systematic Review and Meta-analysis.
    J Neurogastroenterol Motil. 2025;31:28-37.
    PubMed    
    Abstract available

  28. LI X, Li X, Xiao H, Xu J, et al
    Meta-analysis of gut microbiota alterations in patients with irritable bowel syndrome.
    Front Microbiol. 2024;15:1492349.
    PubMed    
    Abstract available

  29. TANG R, Jin Y, Xu K, Wu L, et al
    Aberrant functional connectivity patterns in the pregenual anterior cingulate cortex and anterior midcingulate cortex of patients with irritable bowel syndrome accompanied by depressive symptoms.
    Brain Imaging Behav. 2025 Jan 7. doi: 10.1007/s11682-024-00964.
    PubMed    
    Abstract available

  30. FRASER K, James SC, Young W, Gearry RB, et al
    Characterisation of the Plasma and Faecal Metabolomes in Participants with Functional Gastrointestinal Disorders.
    Int J Mol Sci. 2024;25:13465.
    PubMed    
    Abstract available

  31. HAGHBIN H, Hasan F, Gangwani MK, Zakirkhodjaev N, et al
    Efficacy of Dietary Interventions for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.
    J Clin Med. 2024;13:7531.
    PubMed    
    Abstract available

  32. ZHAO Y, Zhu S, Dong Y, Xie T, et al
    The Role of Gut Microbiome in Irritable Bowel Syndrome: Implications for Clinical Therapeutics.
    Biomolecules. 2024;14:1643.
    PubMed    
    Abstract available

  33. BELL L, Fordham B, Mumtaz S, Yaman R, et al
    Using Natural Language Processing and Social Media Data to Understand the Lived Experience of People with Fibromyalgia.
    Healthcare (Basel). 2024;12:2511.
    PubMed    
    Abstract available

  34. SOEBY M, Clausen L, Richelsen B, Gribsholt SB, et al
    Patterns of Medical Diagnoses Before and After a Diagnosis of Anorexia Nervosa: A Danish Nationwide Cohort Study.
    Int J Eat Disord. 2025 Jan 6. doi: 10.1002/eat.24340.
    PubMed    
    Abstract available

  35. VERMEIJDEN NK, de Silva L, Manathunga S, Spoolder D, et al
    Epidemiology of Pediatric Functional Abdominal Pain Disorders: A Meta-Analysis.
    Pediatrics. 2025 Jan 7:e2024067677. doi: 10.1542/peds.2024-067677.
    PubMed    
    Abstract available

  36. SAHA S, Schnabl B
    Modulating the microbiome in chronic liver diseases- current evidence on the role of fecal microbiota transplantation.
    Expert Rev Gastroenterol Hepatol. 2025 Jan 6. doi: 10.1080/17474124.2025.2450707
    PubMed    
    Abstract available

  37. LENOVER MOYER MB, Jasani K, Waldman AB, Chinchilli VM, et al
    The Developmental Origins of Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
    Am J Hum Biol. 2025;37:e24209.
    PubMed    
    Abstract available

  38. WANG Q, Liu X, Song D, Wang Q, et al
    Exploring the mechanism and effective compounds of Changan Granule on diarrhea-predominant irritable bowel syndrome via regulating 5-hydroxytryptamine signaling pathway in brain-gut axis.
    Phytomedicine. 2024;136:156350.
    PubMed    
    Abstract available

  39. HAZAN S, Bao G, Vidal A, Sfera A, et al
    Gut Microbiome Alterations Following Oral Serum-Derived Bovine Immunoglobulin Administration in the Management of Dysbiosis.
    Cureus. 2024;16:e75884.
    PubMed    
    Abstract available

  40. JOHNSON T, Jahnke AR, Reindel K
    Using Osteopathic Manipulative Therapy to Treat Irritable Bowel Syndrome and Severe Refractory Gastroesophageal Reflux Disease: A Case Report.
    Cureus. 2024;16:e75811.
    PubMed    
    Abstract available

  41. ALLAM DMM, Ali Abdel Ghaffar H, Mostafa Elshamy A, Abdelmotaal Safa M, et al
    Effect of Pilates exercises on symptoms of irritable bowel syndrome in women: a randomized controlled trial.
    Arch Physiother. 2024;14:170-181.
    PubMed    
    Abstract available

  42. AKRAM U, Rehman OU, Fatima E, Nadeem ZA, et al
    The Efficacy of Lubiprostone in Patients of Constipation: An Updated Systematic Review and Meta-Analysis.
    JGH Open. 2025;9:e70070.
    PubMed    
    Abstract available

  43. SZCZEPANKOWSKA AK, Cukrowska B, Aleksandrzak-Piekarczyk T
    Complete genome sequence of Bifidobacterium animalis subsp. lactis BI040, a probiotic strain with multiple health benefits from the NORDBIOTIC collection.
    Microbiol Resour Announc. 2025 Jan 17:e0111724. doi: 10.1128/mra.01117.
    PubMed    
    Abstract available

  44. BARBARO MR, Bianco F, Cremon C, Marasco G, et al
    Lactiplantibacillus plantarum (CECT7484 and CECT7485) and Pedioccoccus acidilactici (CECT7483) enhance actin cytoskeleton and CYP1A1 expression restoring epithelial permeability alterations induced by irritable bowel syndrome mediators.
    Gut Microbes. 2025;17:2452235.
    PubMed    
    Abstract available

  45. KUMAR A, Vallabhaneni P
    Anxiety disorders presenting as gastrointestinal symptoms in children - a scoping review.
    Clin Exp Pediatr. 2025 Jan 13. doi: 10.3345/cep.2024.01732.
    PubMed    
    Abstract available

  46. BEGRE S, Fox M, Jordi SBU, Misselwitz B, et al
    [Functional disorders in chronic inflammatory bowel disease: the gut-brain axis].
    Inn Med (Heidelb). 2025 Jan 14. doi: 10.1007/s00108-024-01832.
    PubMed    
    Abstract available

  47. DING H, Jiang Y, Sun Q, Song Y, et al
    Integrating genetics and transcriptomics to characterize shared mechanisms in digestive diseases and psychiatric disorders.
    Commun Biol. 2025;8:47.
    PubMed    
    Abstract available

  48. QUIGLEY EM
    Small intestinal bacterial overgrowth: from malabsorption to misinterpretation.
    Minerva Gastroenterol (Torino). 2025 Jan 13. doi: 10.23736/S2724-5985.24.03781.
    PubMed    
    Abstract available

  49. ZHOU S, Zi J, Hu Y, Wang X, et al
    Genetic correlation, pleiotropic loci and shared risk genes between major depressive disorder and gastrointestinal tract disorders.
    J Affect Disord. 2025;374:84-90.
    PubMed    
    Abstract available

  50. VALITUTTI F, Mennini M, Monacelli G, Fagiolari G, et al
    Intestinal permeability, food antigens and the microbiome: a multifaceted perspective.
    Front Allergy. 2025;5:1505834.
    PubMed    
    Abstract available

  51. STEIN T, Collins S, St Louis J
    The prevalence of hypermobile Ehlers-Danlos syndrome at a gender-affirming primary care clinic.
    SAGE Open Med. 2025;13:20503121251315021.
    PubMed    
    Abstract available

  52. YING J, Zhang MW, Wei KC, Wong SH, et al
    Influential articles in autism and gut microbiota: bibliometric profile and research trends.
    Front Microbiol. 2025;15:1401597.
    PubMed    
    Abstract available

  53. TABA N, Fischer K, Estonian Biobank Research Team, Org E, et al
    A novel framework for assessing causal effect of microbiome on health: long-term antibiotic usage as an instrument.
    Gut Microbes. 2025;17:2453616.
    PubMed    
    Abstract available

  54. WEI JJ, Zhang PH, Yang ZY, Liu LP, et al
    Colonoscopic administration of probiotics to treat irritable bowel syndrome with predominant diarrhea: a randomized placebo-controlled clinical trial.
    Surg Endosc. 2025 Jan 23. doi: 10.1007/s00464-025-11542.
    PubMed    
    Abstract available

  55. DING L, Duan J, Yang T, Yuan M, et al
    Efficacy of fermented foods in irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Front Nutr. 2025;11:1494118.
    PubMed    
    Abstract available

  56. PAN B, Pan Y, Huang YS, Yi M, et al
    Efficacy and safety of gut microbiome-targeted treatment in patients with depression: a systematic review and meta-analysis.
    BMC Psychiatry. 2025;25:64.
    PubMed    
    Abstract available

  57. BLACK CJ, Ford AC
    An evidence-based update on the diagnosis and management of irritable bowel syndrome.
    Expert Rev Gastroenterol Hepatol. 2025.
    PubMed    
    Abstract available

  58. LI M, Zhuo X, Liu Y, You J, et al
    PPARgamma activation attenuates neonatal CRD-induced visceral pain sensitization and anxiety in male rats by alleviating oxidative stress.
    BMC Gastroenterol. 2025;25:22.
    PubMed    
    Abstract available

  59. ALMABRUK BA, Bajafar AA, Mohamed AN, Al-Zahrani SA, et al
    Efficacy of Probiotics in the Management of Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
    Cureus. 2024;16:e75954.
    PubMed    
    Abstract available

  60. BALKRISHNA A, Sinha S, Shukla S, Bhattacharya K, et al
    Anti-ulcerogenic activity of the marine-pearl derived medicine mukta Pishti in Rat model of pylorus ligation-induced peptic ulcer.
    J Ethnopharmacol. 2025;342:119378.
    PubMed    
    Abstract available

  61. G B, M B, P P, V S, et al
    Bile acid diarrhea in patients with chronic diarrhea. Current appraisal and recommendations for clinical practice.
    Dig Liver Dis. 2025 Jan 17:S1590-8658(24)01144-7. doi: 10.1016/j.dld.2024.
    PubMed    
    Abstract available

  62. HOUGHTON LA, Gao S, Gilbert SA, Coffin B, et al
    Clinical Trial: Study to Investigate the Efficacy and Safety of the Alpha-2-Delta Ligand PD-217,014 in Patients With Irritable Bowel Syndrome.
    Aliment Pharmacol Ther. 2025 Jan 15. doi: 10.1111/apt.18487.
    PubMed    
    Abstract available

  63. CHEN LJ, Plantinga AM, Burr R, Cain K, et al
    Exploration of Cytokines and Microbiome Among Males and Females with Diarrhea-Predominant Irritable Bowel Syndrome.
    Dig Dis Sci. 2025 Jan 8. doi: 10.1007/s10620-024-08836.
    PubMed    
    Abstract available

  64. HUNG KW, Leiman DA, Kaza A, Watson R, et al
    AGA Institute Quality Indicator Development for Irritable Bowel Syndrome.
    Gastroenterology. 2025 Jan 15:S0016-5085(24)05666.
    PubMed    



  65. Correction: Prevalence of irritable bowel syndrome and functional dyspepsia after acute gastroenteritis: systematic review and meta-analysis.
    Gut. 2025;74:e12.
    PubMed    


  66. JAIN A, Ramchandani S, Bhatia S
    Gastrointestinal symptoms and disorders of gut-brain interaction in pregnancy.
    Indian J Gastroenterol. 2025 Jan 4. doi: 10.1007/s12664-024-01705.
    PubMed    
    Abstract available

  67. PISKORZ MM, Stefanolo JP, Ibanez A, Eugenia H, et al
    Gut-brain Axis and Irritable Bowel Syndrome During the Lockdown due to the SARS-CoV-2 Pandemic: A Survey-based Study.
    J Clin Gastroenterol. 2024 Dec 27. doi: 10.1097/MCG.0000000000002123.
    PubMed    
    Abstract available

  68. YU QX, Wang DD, Dong PJ, Zheng LH, et al
    Probiotics Combined With Trimebutine for the Treatment of Irritable Bowel Syndrome Patients: A Systematic Review and Meta-Analysis.
    J Gastroenterol Hepatol. 2025 Jan 8. doi: 10.1111/jgh.16858.
    PubMed    
    Abstract available

  69. AKHLAQ S, Kazmi N, Kazmi SMH, Atiq M, et al
    Somatization symptomology and its association with stress in patients with irritable bowel syndrome.
    PLoS One. 2025;20:e0312506.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.


;